LIV001

Liveome Inc. · Phase 1 active Small molecule

At a glance

Generic name	LIV001
Sponsor	Liveome Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC) (PHASE1)
A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC) (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

LIV001 CI brief — competitive landscape report
LIV001 updates RSS · CI watch RSS
Liveome Inc. portfolio CI